George A. Eldridge, SEE REMARKS at Aerovate Therapeutics, Inc. (AVTE), sold 24,990 shares at $31.23 ($780K) on 2024-04-01, disclosed to the SEC on 2024-04-03.
Scheduled sale ($780k) by SEE REMARKS under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.23 | 12,495 | $390K | 50.0% |
| 2 | $31.23 | 12,495 | $390K | 50.0% |
| Total | $31.23 avg | 24,990 | $780K | 100% |
| Filing → |
| AVTE | SELL | 2024-03-14 | $204K | — | Filing → |
| AVTE | SELL | 2024-03-11 | $736K | — | Filing → |
| AVTE | SELL | 2022-12-13 | $479K | — | Filing → |